PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3083/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Eisai
A complaint was brought by the PMCPA Director against Eisai.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code (Applicabl…
Clauses: NONE
🔒 Subscribers only
AUTH/3106/10/18
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag Limited made a voluntary admission that a Zytiga (abiraterone) advertisement (ref PHGB/ZYT/0716/0009(1)) was published twice with out-of-date prescribing information (PI).The ad appea…
Clauses: 4.1
🔒 Subscribers only
AUTH/3082/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Bristol
A complaint was brought by the PMCPA Director against Bristol-Myers Squibb.The subject matter related to clinical trial disclosure.The case was assessed under the ABPI Code year 2016.The PMCPA reco…
Clauses: NONE
🔒 Subscribers only
AUTH/3107/10/18
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo website product
A UK health professional complained that pages on Daiichi-Sankyo’s website promoted prescription-only medicines (POMs) to the public.The complainant said the site did not separate patient and hea…
Clauses: NONE
🔒 Subscribers only
AUTH/3077/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Otsuka UK
A complaint was brought by the PMCPA Director against Otsuka UK.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code of Pra…
Clauses: NONE
🔒 Subscribers only
AUTH/3111/10/18
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Pfizer
A contactable complainant (a concerned UK health professional) alleged prescribing information (PI) on Pfizer’s PfizerPro website for Xeljanz (tofacitinib), Sutent (sunitinib) and Champix (vareni…
Clauses: NONE
🔒 Subscribers only
AUTH/3076/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
AstraZeneca
A complaint was brought by the Director against AstraZeneca.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code (Applicabl…
Clauses: NONE
🔒 Subscribers only
AUTH/3121/11/18
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Biogen Idec
A hospital doctor complained about an Imraldi (adalimumab) mailing sent by Biogen Idec to their home address which required a signature, meaning they had to collect it from a post office five miles…
Clauses: NONE
🔒 Subscribers only
AUTH/3075/9/18
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Lundbeck
A complaint was brought by the PMCPA Director against Lundbeck.The subject matter related to clinical trial disclosure.The matter was assessed under the ABPI Code of Practice 2016.The case was conc…
Clauses: NONE
🔒 Subscribers only
AUTH/3126/11/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Alliance Pharmaceuticals
A UK health professional complained about an Alliance Pharmaceuticals LinkedIn post announcing the UK launch of Xonvea (doxylamine succinate 10mg/pyridoxine hydrochloride 10mg) for nausea and vomit…
Clauses: NONE
🔒 Subscribers only
AUTH/3099/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Allergan
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) ranked sponsors’ compliance with posting results to the EU Clinical Trials Register (EUCTR) …
Clauses: NONE
🔒 Subscribers only
AUTH/3127/12/18
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
MSD
Merck Sharp & Dohme (MSD) voluntarily admitted an advertisement for Keytruda (pembrolizumab) did not contain prescribing information.The material was created and certified for use in a congress…
Clauses: NONE
🔒 Subscribers only
AUTH/3097/9/18
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Teva
The PMCPA Director took up a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted trial results to the EU Clinical Trials Register (EUCTR) by …
Clauses: NONE
🔒 Subscribers only
AUTH/3132/12/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (described as a concerned health professional) complained about advertisements on Facebook and Twitter for meetings allegedly sponsored by pharmaceutical c…
Clauses: NONE
🔒 Subscribers only
AUTH/3102/9/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Lilly
A BMJ paper (Goldacre et al, published online 12 September 2018) assessed whether sponsors posted due clinical trial results to the EU Clinical Trials Register (EUCTR) within the European Commissio…
Clauses: NONE
🔒 Subscribers only
AUTH/3074/9/18
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Director v AbbVie (AUTH/3074/9/18)
A complaint was brought by the Director against AbbVie.The subject matter related to clinical trial disclosure.The case was assessed under the ABPI Code year 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/3072/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Servier
A matter relating to clinical trial disclosure involving Servier was considered following a complaint by the Director.The case was assessed under the ABPI Code of Practice 2016.The PMCPA determined…
Clauses: NONE
🔒 Subscribers only
AUTH/3079/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Pfizer
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted due results on the EU Clinical Trials Register (EUCTR) by the…
Clauses: NONE
🔒 Subscribers only
AUTH/3084/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
The PMCPA Director took up a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted due results to the EU Clinical Trials Register (EUCTR) by th…
Clauses: NONE
🔒 Subscribers only
AUTH/3118/11/18
Off-label Promotion Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Tesaro
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) ranked sponsors’ compliance with posting trial results to the EU Clinical Trials Register (E…
Clauses: NONE
🔒 Subscribers only
AUTH/3087/9/18
Data & Publications Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper reported that GlaxoSmithKline (GSK) had 33 “due trials” without results on EUCTR (reported disclosure rate 88.7%). GSK …
Clauses: NONE
🔒 Subscribers only
AUTH/3030/4/18
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Anonymous employee complaint against UCB (no breach)
An anonymous, non-contactable complainant (describing themselves as a senior key account manager at UCB Pharma) alleged UCB continually breached the Code.Allegations included: meeting slides used w…
Clauses: NONE
🔒 Subscribers only
AUTH/3125/11/18
Data & Publications Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda v Merck Sharp & Dohme
Takeda (Vipidia/alogliptin) raised inter-company dialogue with Merck Sharp & Dohme (Januvia/sitagliptin) about a “Sitagliptin Information Pack” that mentioned alogliptin and displayed the i…
🔒 Subscribers only
AUTH/3021/2/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Shire
An anonymous complainant raised a concern about a meeting advertised on LinkedIn.The company involved was Shire.The case was considered under the PMCPA complaints process.
Clauses: NONE
← Prev 27 28 29 30 31 32 33 Next → Page 30 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews